TITLE

Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches

AUTHOR(S)
Coronado, Gloria D.; Rivelli, Jennifer S.; Fuoco, Morgan J.; Vollmer, William M.; Petrik, Amanda F.; Keast, Erin; Barker, Sara; Topalanchik, Emily; Jimenez, Ricardo
PUB. DATE
January 2018
SOURCE
JGIM: Journal of General Internal Medicine;Jan2018, Vol. 33 Issue 1, p72
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: The Community Preventive Services Task Force recommends multi-component interventions, including patient reminders, to improve uptake of colorectal cancer screening.Objective: We sought to compare the effectiveness of different forms of reminders for a direct-mail fecal immunochemical test (FIT) program.Design: Patient-randomized controlled trial.Participants: 2772 adults aged 50-75, not up to date with colorectal cancer screening recommendations, with a clinic visit in the previous year at any of four participating health center clinics.Intervention: Participants were mailed an introductory letter and FIT. Those who did not complete their FIT within 3 weeks were randomized to receive (1) a reminder letter, (2) two automated phone calls, (3) two text messages, (4) a live phone call, (5) a reminder letter and a live phone call, (6) two automated phone calls and a live phone call, or (7) two text messages and a live phone call. Patients with a patient portal account were sent two email reminders, but were not randomized.Main Measures: FIT return rates for each group, 6 months following randomization.Key Results: A total of 255 (10%) participants returned their FIT within 3 weeks of the mailing. Among randomized participants (n = 2010), an additional 25.5% returned their FITs after reminders were delivered (estimated overall return rate = 32.7%). In intention-to-treat analysis, compared to the group allocated to receive a reminder letter, return rates were higher for the group assigned to receive the live phone call (OR = 1.51 [1.03-2.21]) and lower for the group assigned to receive text messages (OR = 0.66 [0.43-0.99]). Reminder effectiveness differed by language preference.Conclusions: Our data suggest that FIT reminders that included a live call were more effective than reminders that relied solely on written communication (a text message or letter).Trial Registration: ClinicalTrials.gov/ctc2/show/NCT01742065 .
ACCESSION #
127146885

 

Related Articles

  • Fewer than half of appropriate candidates receive any colorectal cancer screening.  // Modern Medicine;May96, Vol. 64 Issue 5, p60 

    Presents an abstract of the article `Screening of colorectal cancer--United States, 1992-1993, and new guidelines,' published in `MMWR' journal on February 9, 1996.

  • Characteristics of colorectal cancer at presentation.  // American Family Physician;3/1/1994, Vol. 49 Issue 4, p913 

    Presents an overview of the article on the diagnosis of colorectal cancer, published in the `Family Practice Research Journal' in December 1993. Incidence in the United States; Detection during the asymptomatic phase of the cancer; Manifestations of early-stage cancer.

  • The Performance of Three-Sample Qualitative Immunochemical Fecal Test to Detect Colorectal Adenoma and Cancer in Gastrointestinal Outpatients: An Observational Study. Wu, Dong; Luo, Han-Qing; Zhou, Wei-Xun; Qian, Jia-Ming; Li, Jing-Nan // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Background: Repeated qualitative fecal immunochemical test (qlFIT) is a clinical strategy widely used to detect lower gastrointestinal lesions, but its diagnostic power has not been assessed in opportunistic screening for colorectal neoplasia. Objective: This study aimed to determine the...

  • Will the real screening test please step forward? Rees, Michael K. // Modern Medicine;May96, Vol. 64 Issue 5, p68 

    Editorial. Comments on the US Preventive Services Task Force's recommendations on the use of fecal occult blood testing (FOBT) to detect colorectal cancer. Omissions in publication `Guide to Clinical Preventive Services, Report of the US Preventive Service Task Force, 1995'; Predictive value...

  • FDA panel: CT colonography viable colorectal cancer screening option.  // Hem/Onc Today;10/10/2013, Vol. 14 Issue 19, p31 

    The article reports that the Gastroenterology-Urology Devices Panel and Radiological Devices Panel of the U.S. Food and Drug Administration (FDA) found that computed tomography (CT) colonography is a viable tool for the diagnosis of colorectal cancer for asymptomatic patients older than 50 years.

  • Daring to hope. Henderson, Cherie // Self;Oct2007, Vol. 29 Issue 10, p186 

    A personal narrative is presented that explores the author's experience of being diagnosed with rectal cancer, surviving and learning to trust in the future again.

  • Multi-Target Stool DNA Test: A New High Bar for Noninvasive Screening. Ahlquist, David // Digestive Diseases & Sciences;Mar2015, Vol. 60 Issue 3, p623 

    Stool DNA testing has evolved into what is now a highly accurate and well-validated test for the screen detection of colorectal neoplasia. An optimized and automated multi-target stool DNA test (MT-sDNA) has achieved the same high point-sensitivities as reported for colonoscopy and significantly...

  • FIT for CRC screening in Ireland?  // PharmacoEconomics & Outcomes News;3/17/2012, Issue 649, p8 

    The article reports on a study on the use of biennial faecal immunochemical testing (FIT) as a colorectal cancer (CRC) screening strategy in Ireland.

  • Why many patients fail to comply with colon cancer screening programs.  // Modern Medicine;Jun98, Vol. 66 Issue 6, p11 

    Presents an abstract of the article `Patient Participation in Colon Cancer Screening Programs,' by A.M. DiPalma, S.E. Barnes, et al from the `South Medical Journal' dated April 1998.

  • Effect of bowel obstruction on stage IV colorectal cancer. WEI CHEN; XIAO-PING TAN; JUN-WEN YE; QIN LIU; QINGLI ZENG; LEI WANG; JIAN-PING WANG // Molecular & Clinical Oncology;2014, Vol. 2 Issue 3, p308 

    Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, with a high mortality rate, particularly among patients with advanced-stage disease complicated by bowel obstruction. The present study aimed to investigate the value of different surgical procedures and potential...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics